Document Detail

Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial.
MedLine Citation:
PMID:  16163369     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE:To assess, among premature infants with early respiratory distress syndrome (RDS), the effect of one dose of intratracheally administered surfactant followed by extubation to nasal continuous positive airway pressure (NCPAP) on subsequent mechanical ventilation (MV), when compared with NCPAP alone. STUDY DESIGN:Randomized, blinded trial in infants 29 to 35 weeks' gestation with mild-to-moderate RDS requiring supplemental oxygen and NCPAP. Infants were randomized to intubation, surfactant treatment, and immediate extubation (surfactant group N=52), or to no intervention (control group N=53). All infants were subsequently managed with NCPAP. RESULTS:Need for later MV was 70% in the control group and 50% in the surfactant group. Surfactant group subjects had lower inspired oxygen fraction (FiO(2)) after study intervention and were less likely to require subsequent surfactant. Overall surfactant use, duration of O(2) therapy, length of stay, and bronchopulmonary dysplasia were unaffected. CONCLUSION:Among premature infants with mild-to-moderate RDS, transient intubation for surfactant administration reduces later MV.
Ann Reininger; Rubia Khalak; James W Kendig; Rita M Ryan; Timothy P Stevens; Linda Reubens; Carl T D'Angio
Related Documents :
19925369 - Respiratory syncytial virus risk factors in late preterm infants.
16337029 - What is the best screening method to detect serratia marcescens colonization during an ...
23921419 - Resuscitation intensity at birth is associated with changes in brain metabolic developm...
1554199 - Thrombin/antithrombin iii complex formation in the neonatal respiratory distress syndrome.
8286159 - Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neon...
12076469 - Early surfactant administration with brief ventilation vs selective surfactant and cont...
8206419 - Habitat, density and group size of primates in a brazilian tropical forest.
6372039 - Anaerobes as normal oral flora.
11746029 - Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid sep...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  25     ISSN:  0743-8346     ISO Abbreviation:  J Perinatol     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-10-27     Completed Date:  2006-01-17     Revised Date:  2010-03-23    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  703-8     Citation Subset:  IM    
Copyright Information:
Journal of Perinatology (2005) 25, 703-708. doi:10.1038/; published online 15 September 2005.
Strong Children's Research Center, University of Rochester, Rochester, NY 14642, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Products / administration & dosage*
Continuous Positive Airway Pressure
Infant, Newborn
Respiration, Artificial*
Respiratory Distress Syndrome, Newborn / drug therapy*
Time Factors
Reg. No./Substance:
0/Biological Products; 108778-82-1/beractant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Validity of hospital discharge data for identifying infants with cardiac defects.
Next Document:  Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunct...